Ashar Bhavesh Insider Trades

Insider Trading History

Track insider trading activity for Ashar Bhavesh. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tyra Biosciences
Tyra Biosciences TYRA
Chief Operating Officer
Holding Value $1.44M 50,295 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 65,308 shares
$33.93
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Chief Operating Officer
Holding Value $8.61M 300,000 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.24M 300,000 shares
$20.81
$28.69
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jul 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.9M 295,615 shares
$46.99
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.92M 62,053 shares
Last Trade
Feb 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.2k 1,016 shares
$61.19
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.96M 63,069 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 50,615 shares
$43.00
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.15M 45,746 shares
Last Trade
Jan 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$88.8k 2,284 shares
$38.86
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.26M 48,030 shares
Last Trade
Jan 05, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$146k 3,825 shares
$38.19
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.44M 51,855 shares
Last Trade
Jan 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$171k 4,475 shares
$38.19
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.65M 56,330 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$86.9k 1,824 shares
$47.62
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.73M 58,154 shares
Last Trade
Feb 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$238k 4,834 shares
$49.32
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $3.06M 65,121 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$143k 3,222 shares
$44.38
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $3.11M 66,210 shares
Last Trade
Jan 08, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$60.2k 1,449 shares
$41.53
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $3.18M 67,659 shares
Last Trade
Jan 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$95.2k 2,507 shares
$37.96
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $3.52M 75,000 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 75,000 shares
$38.40
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.05M 43,721 shares
Last Trade
Apr 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.7k 1,375 shares
$25.25
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $2.12M 45,096 shares
Last Trade
Jan 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45.8k 1,665 shares
$27.52
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $4.7M 100,000 shares
Last Trade
Oct 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.7M 100,000 shares
$26.98
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $1.13M 24,098 shares
Last Trade
Apr 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$83.3k 1,464 shares
$56.90
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $1.91M 40,710 shares
Last Trade
Jan 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 40,710 shares
$59.46
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Commercial Officer
Holding Value $4.32M 92,000 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.68M 92,000 shares
$72.61
$46.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up